In November, we released an update to Medable Studio titled Medable AI.
This latest update furthers Studio's unique value proposition, offering sponsors and CROs unprecedented control over the study creation and launch process, as well as scalability, speed, and streamlining of operations.
This provides the easiest, fastest path to study launch in the industry to date.
If this already sounds like something you could use, check out a demo or an in-depth look at its feature set here.
For everyone else, read below to discover what exactly Medable AI has to offer.
What is it?
Medable’s AI capabilities are advanced tools designed to enhance clinical trial processes by automating and optimizing the eCOA build experience. These capabilities leverage cutting-edge AI technology to automatically generate the digital version of an eCOA from the paper version (PDF). Medable’s AI empowers users to accomplish repetitive build activities, such as repeated scales for long questionnaires, using simple prompts in our intelligent chat interface.
Medable Studio with AI also breaks through the roadblock of linear development. Traditionally, clinical trial development has followed a linear, sequential workflow.
This involves:
- Initiating the project with a kickoff meeting,
- Discussing needs,
- Drafting spec documents,
- Going back and forth with vendors and their coders for changers,
- Obtaining final approval, and finally,
- Commencing the build phase.
While comprehensive, this approach is often time-consuming and requires more resources and agility to adapt to evolving requirements, regulations, and, most importantly - changes.
For example, creating a validated instrument, creating screenshots, and gaining author approval can take many cycles between the sponsor and the author. Similar issues occur with the translation and linguistic review processes. These cumbersome processes can delay your study's start.
Not only does this take time, it’s harder to manage. Medable Studio eliminates this issue.
Why is it different?
Medable stands out in the clinical trial landscape due to its unique integration of Generative AI with a focus on operational efficiency. It helps ensure that eCOA stays off the critical path for FPI. Unlike traditional methods that rely heavily on manual input and many clicks, Medable's approach uses AI to create dynamic, adaptable solutions that cater specifically to the needs of eCOA builders. This includes innovative ways to accomplish repetitive actions with a simple chat interface.
Our competitors focus on traditional interfaces for reusing repetitive scale screens 15 times for a single eCOA. In contrast, Medable’s AI can accomplish a 15 VRS screen eCOA with a simple prompt: ex Create 15 VRS (Verbal rating scale) screens with the following option values (None, Mild, Moderate, Severe, Extremely Severe).
Why should the industry care?
The big impact of Medable AI is that it has the potential to fundamentally alter how clinical trial software is built and deployed forever. By making the build process more efficient and innovative, we can bring life-saving treatments to market faster. In an era where speed and adaptability are crucial, Medable is leading the way toward a more responsive and practical clinical research ecosystem.
Frequently Asked Questions
What AI models does Medable AI use?
A: Currently, Medable AI leverages pre-trained models. So, customer data is not used to train models. All models are used in dedicated, secure environments, and all customer data is secured and isolated.
Q: Does Medable AI interact with Patient data?
A: No. Medable AI is ONLY used as an operational tool to build out elements of your study. It does not touch any patient data.
Q: Is this available in the industry right now?
A: No. Medable is the first to incorporate Generative AI into the study build process, drastically cutting build time and getting us closer to our one-day study start vision.
Likewise, focus on traditional interfaces for reusing repetitive scale screens (i.e. building 15 times for a single eCOA), whereas Medable’s AI can accomplish this same task with a simple prompt : ex Create 15 VRS (Verbal rating scale) screens with the following option values (None, Mild, Moderate, Severe, Extremely Severe).
Q: How do you ensure quality and validate what is built? How do you ensure that a human is still in control?
A: Medable Studio has a built-in review and approval workflow. Whether the instrument is built by Medable AI or manually through our point-and-click interface, it still has to go through the review and approval process, which the system's user completes. Medable AI improves productivity by automating repetitive configurations.
